Topic: Eli Lilly’s retatrutide Phase 3 success — plans FDA filing for “Triple-G” obesity peptide (July 23, 2026) You’ve heard of Ozempic (semaglutide) and Mounjaro (tirzepatide) — the injectable weight loss drugs that have dominated headlines for the past two…
Topic: FDA Committee votes to allow compounding of BPC-157, KPV, TB-500, MOTS-c, Semax & Epitalon (July 23, 2026) If you’ve spent any time in fitness circles, longevity clinics, or even just scrolling wellness social media, you’ve probably heard names like…
Topic: Kither Biotech’s KIT2014 inhaled peptide completes Phase I trial (June 2026) If you or someone you love has COPD, cystic fibrosis, or chronic bronchitis, you know that current treatments are limited. Inhalers help open airways. Steroids reduce inflammation. But…
